Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Pathologie CVD from Gent, company number BE0780798926, closed financial year 2025 with a result of € 450,392 after tax. For that financial year Pathologie CVD recorded a gross margin of € 690,953 and equity of € 554,674. Compared with financial year 2024, the result moved from € 413,704 to € 450,392. Profitable, and profit is growing. The buffer shrank hard: equity is 54 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 554,674
▼ 54% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 450,392
▲ 9% vs 2024
Profit after tax over the fiscal year.
€ 63,863
▼ 81% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.1 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 57,798
▲ € 54,467 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 665,789
▼ 13% vs 2024
€ 98,532 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 862
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,331
▲ € 36,200 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 677,840 | € 548,502 | € 658,309 | € 690,953 | ▲ 5% |
| Profit after taxes | € 453,588 | € 330,990 | € 413,704 | € 450,392 | ▲ 9% |
| Equity | € 459,588 | € 790,578 | € 1,204,282 | € 554,674 | ▼ 54% |
| Total debts | € 1,057,397 | € 960,060 | € 774,143 | € 767,850 | ▼ 1% |
| Cash | € 372,482 | € 681,271 | € 335,027 | € 63,863 | ▼ 81% |
| Retained profit | € 453,588 | € 784,578 | € 1,198,282 | € 548,674 | ▼ 54% |
| Dividend | € 0 | € 0 | € 0 | € 1,100,000 | |
| Bank debt | € 953,251 | € 858,767 | € 762,953 | € 665,789 | ▼ 13% |
| Balance sheet total | € 1,516,985 | € 1,750,638 | € 1,978,425 | € 1,322,524 | ▼ 33% |
Key figures of Pathologie CVD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pathologie CVD?
What happened at Pathologie CVD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 450,392 (▲ 9% vs 2024). filed late Source: NBB ↗
- New establishment in Gent. KBO
- Caroline Van den Broecke became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 453,588 profit in 2022 to € 450,392 profit in 2025.
Paid € 529,246 in corporate taxes since 2022.
Best year ever: 2022, with € 453,588 profit.
Paid out € 1.1 million in dividends to the owners in total.
Management
Behind Pathologie CVD is Caroline Van den Broecke.
Directors
According to the 2025 annual accounts
Caroline Van den Broecke
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Krijgslaan 120
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0780.798.926
- VAT number
- BE 0780.798.926
- Registered office
- Krijgslaan 120, 9000 Gent
- Names & denominations
- Pathologie CVD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 January 2022
- Peppol
- Active · Active since 28 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten